MGX · Metagenomi Therapeutics, Inc.
Market Cap
$44.95M
Shares
37.78M
Metagenomi Therapeutics, Inc. Earnings Call Transcripts
Quarterly earnings calls for Metagenomi Therapeutics, Inc. (MGX), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
Earnings call
FY25 · Q3
2025-11-12
Metagenomi Therapeutics, Inc. (MGX) Q3 2025 Earnings Call
Revenue
$8.66M
▼ 24.8% YoY Diluted EPS
$-0.55
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-17
Metagenomi Therapeutics, Inc. (MGX) Q4 2024 Earnings Call
Revenue
$9.61M*
▼ 22.5% YoY
Rev · 6q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-13
Metagenomi Therapeutics, Inc. (MGX) Q3 2024 Earnings Call
Revenue
$11.51M
▼ 6.9% YoY Diluted EPS
$-0.51
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-01
Metagenomi Therapeutics, Inc. (MGX) Q1 2024 Earnings Call
Revenue
$11.16M
▲ 28.9% YoY Diluted EPS
$-1.19
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Showing 1–4 of 4 earnings calls
Key facts
CIK
1785279
CUSIP
59102M104
13F (30d)
40 filings
40 filers
Visit website
Investor relations